Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05382156 · ClinicalTrials.gov registry record
Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome
A clinical trial of Endogenous Cushing's Syndrome, sponsored by Recordati Group.
- Active
- Registry status
- 206
- Enrollment target
- 20
- Study locations
NCT05382156 is a study of Endogenous Cushing's Syndrome that is active but no longer recruiting, run by Recordati Group. The registered enrollment target is 206 participants. The trial reports 20 study locations across 15 states.
The verdict
NCT05382156, a study of Endogenous Cushing's Syndrome, is active but no longer recruiting, sponsored by Recordati Group.
- ACTIVE NOT RECRUITING
- Registry status
- 206 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a non-interventional, multinational, multi-centre study with primary data collection, to further document the safety and efficacy of osilodrostat administered in routine clinical practice in patients treated with osilodrostat for endogenous Cushing's Syndrome
Conditions Studied
Interventions
- DRUG Osilodrostat
Study Locations (20)
Other
- Hôpital Haut-Lévêque - Bordeaux
- Hospices Civiles de Lyon - Bron
- CHU de Grenoble site Nord - Grenoble
- Groupement Hospitalier Sud - Hôpital Bicêtre - Le Kremlin-Bicêtre
- Hopital Claude Huriez - CHRU Lille - Lille
New York
- NYU Grossman School of Medicine - New York
- Memorial Sloan-Kettering Cancer Center (MSKCC) - New York - New York
Arizona
- Barrow Neurological Institute - Phoenix
Georgia
- Emory University School - Atlanta
Illinois
- Northwestern University - Chicago
Indiana
- Indiana University Schl-med - Indianapolis
Kentucky
- St Elizabeth Physicians - Covington
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2022-06-13 |
| Est. Completion | 2027-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05382156
The ClinicalTrials.gov registry entry for NCT05382156 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Recordati Group, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Endogenous Cushing's Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Osilodrostat is the first listed.
NCT05382156 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Other, New York, Arizona.
Frequently Asked Questions
What is clinical trial NCT05382156 about?
NCT05382156 is a clinical study titled "Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome". This is a non-interventional, multinational, multi-centre study with primary data collection, to further document the safety and efficacy of osilodrostat administered in routine clinical practice in patients treated with osilodrostat for endogenous Cushing's Syndrome
What is the current status of trial NCT05382156?
This trial is currently active not recruiting. The enrollment target is 206 participants. The study started on 2022-06-13. Estimated completion is 2027-08.
What conditions does trial NCT05382156 study?
This clinical trial studies the following conditions: Endogenous Cushing's Syndrome.
What interventions are being tested in trial NCT05382156?
The interventions under investigation include: Osilodrostat (DRUG).
Who is sponsoring clinical trial NCT05382156?
This trial is sponsored by Recordati Group, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05382156 being conducted?
This trial has 20 study locations across Arizona, Georgia, Illinois, Indiana, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endogenous Cushing's Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.